Tibet Rhodiola Pharmaceutical Holding

Tibet Rhodiola Pharmaceutical Holding Current Assets

The Current Assets of Tibet Rhodiola Pharmaceutical Holding (600211.SS) as of Oct 18, 2026 is 3.65 B CNY. In the previous year, Current Assets was 3.62 B CNY — a change of 0.64% (higher).

Current Assets

3.65 BCNY

YoY

0.64%

Last updated:

Current Assets of Tibet Rhodiola Pharmaceutical Holding is 2025 3.65 B CNY. Current Assets of Tibet Rhodiola Pharmaceutical Holding was 2024 3.62 B CNY. It decreases by 0.64% higher compared to the previous year.

The Tibet Rhodiola Pharmaceutical Holding Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
1.10 B CNY
Jan 1, 2019
1.36 B CNY
Jan 1, 2020
1.35 B CNY
Jan 1, 2021
2.28 B CNY
Jan 1, 2022
2.76 B CNY
Jan 1, 2023
3.45 B CNY
Jan 1, 2024
3.62 B CNY
Jan 1, 2025
3.65 B CNY
The Tibet Rhodiola Pharmaceutical Holding Current Assets history
YEARCurrent AssetsYoY
3.65 BCNY+0.64%
3.62 BCNY+5.09%
3.45 BCNY+25.18%
2.76 BCNY+20.99%
2.28 BCNY+68.53%
1.35 BCNY-0.78%
1.36 BCNY+23.48%
1.10 BCNY+32.04%
835.24 MCNY+25.09%
667.73 MCNY+36.68%
488.55 MCNY-40.72%
824.16 MCNY-10.87%
924.71 MCNY+49.64%
617.95 MCNY+13.39%
545.00 MCNY-16.04%
649.15 MCNY-5.23%
685.01 MCNY+30.08%
526.62 MCNY+28.00%
411.42 MCNY-48.95%
805.91 MCNY+88.51%
427.51 MCNY+31.25%
325.73 MCNY-31.79%
477.54 MCNY+12.90%
422.98 MCNY+54.94%
272.99 MCNY-16.00%
325.01 MCNY+0.93%
322.02 MCNY+293.61%
81.81 MCNY+622.29%
11.33 MCNY-27.29%
15.58 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tibet Rhodiola Pharmaceutical Holding Stock analysis

What does Tibet Rhodiola Pharmaceutical Holding do? Tibet Rhodiola Pharmaceutical Holding Co, listed on the Shanghai Stock Exchange under ticker 600211.SS, operates as a pharmaceutical company based in Lhasa, China. The company's ISIN is CNE000000ZW7. Founded through an IPO on July 21, 1999, it specializes in the manufacture and wholesale of pharmaceutical products. Its headquarters are located in Lhasa, Xizang, and it employs 615 full-time staff. The firm distributes proprietary drug products and processes pharmaceuticals, conducting business primarily across South China, North China, East China, Central China, and overseas markets. The company's website is http://www.xzyy.cn. It does not provide details on specific products, acquisitions, or financial figures beyond the IPO date and employee count. The company focuses on pharmaceutical manufacturing and distribution within its operational regions, with no additional information provided on its product lines or market share. Tibet Rhodiola Pharmaceutical Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tibet Rhodiola Pharmaceutical Holding stock

Current Assets of Tibet Rhodiola Pharmaceutical Holding is 3.65 B CNY in 2025.

Current Assets of Tibet Rhodiola Pharmaceutical Holding changed from 3.62 B CNY to 3.65 B CNY, representing a 0.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Tibet Rhodiola Pharmaceutical Holding since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Tibet Rhodiola Pharmaceutical Holding historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Tibet Rhodiola Pharmaceutical Holding

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Tibet Rhodiola Pharmaceutical Holding